Wednesday, 26 August 2026European Markets

ATOS Stock Went Down By Over 27% In The Last 21 Sessions

Loading stream...

(vianews) - shares of atos (cac 40: ato.pa) fell by a staggering 27.47% in 21 sessions from €15.29 to €11.09 at 14:38 est on thursday, following the last session's downward trend. cac 40 is jumping 0.34% to €7,341.52, after two consecutive sessions in a row of losses.

about atos

atos se provides digital transformation solutions and services worldwide. it offers advanced computing solutions; analytics, artificial intelligence, and automation solutions; cloud solutions; customer journey analytics and digital customer experience; decarbonization solutions; digital consulting; digital workplace solutions; edge computing and internet of things solutions; and modern applications and platforms. the company also provides advance detection and response, data protection and governance, digital workplace security, iot and ot security, trusted digital identities, and cybersecurity solutions; and infrastructure and foundation services. it serves financial services and insurance, healthcare and life sciences, manufacturing, public sector and defense, resources and services, telecom, media, and entertainment industries. the company was incorporated in 1982 and is headquartered in bezons, france.

earnings per share

as for profitability, atos has a trailing twelve months eps of €5.05.

pe ratio

atos has a trailing twelve months price to earnings ratio of 2.2. meaning, the purchaser of the share is investing €2.2 for every euro of annual earnings.

volume

today's last reported volume for atos is 414989 which is 81.23% below its average volume of 1541740.

more news about atos (ato.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com